Pharmaceutical Membrane Filtration Market in terms of revenue was estimated to be worth $10.6 billion in 2024 and is poised to reach $19.6 billion by 2029, growing at a CAGR of 13.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing adoption of single use membrane filters coupled by high purity requirements among end users, increasing R&D spending by government and private organizations, and increasing regulations for membrane filter’s safety by regulatory bodies. Despite this, issues such as membrane fouling, and large capital investment are expected to hinder market growth.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031
The polyethersulfone (PES) membrane filters segment accounted for the largest share of the membrane filters segment in the pharmaceutical membrane filtration market in 2023.
Based on products, the pharmaceutical membrane filtration market is segmented into membrane filters, systems, and other products. Membrane filters segment dominated the market in 2023 and is expected to dominate the market in the forecast period. Membrane filters are further segmented based on material into polyethersulfone (PES) membrane filters, polyvinylidene difluoride (PVDF) membrane filters, nylon membrane filters, polytetrafluoroethylene (PTFE) membrane filters, mixed cellulose ester & cellulose acetate (MCE & CA) membrane filters, polycarbonate track-etched (PCTE) membrane filters, and other membrane filters (PP, PC, CN, gelatin, PETE, and RC). Among these, PES membrane filters are most widely used due to their hydrophilic nature and high flow rates.
The microfiltration segment is estimated to register the highest growth rate during the forecast period in the pharmaceutical membrane filtration market.
Based on technique, the pharmaceutical membrane filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. The other techniques segment includes reverse osmosis and ion exchange. The microfiltration segment is estimated to register the highest growth rate during the forecast period. In the pharmaceutical industry, microfiltration finds applications in clarification, purification of cell broths, the separation of cell debris, and the separation of macromolecules. The technique is used in harvesting cells in upstream bioprocessing.
The Asia Pacific region is the fastest-growing region of the pharmaceutical membrane filtration market in 2023.
Based on the region, the pharmaceutical membrane filtration market is segmented into major regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The Asia Pacific is anticipated to register fastest growth in the pharmaceutical membrane filtration owing to the increasing technological advancement in nanofiber technologies, manufacturing facility expansions by pharmaceutical companies, high government investments & fundings for R&D, and growing biotechnology industries.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=255408031
Key Market Players of Pharmaceutical Membrane Filtration Industry:
Key players in the pharmaceutical membrane filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), 3M Company (US), Parker Hannifin Corporation (US), Repligen Corporation (US), Asahi Kasei Corporation (Japan), Eaton Corporation plc (Ireland), GEA Group (Germany), Corning Incorporated (US), Alfa Laval Corporate AB (Sweden), Donaldson Company, Inc. (US), Saint-Gobain (France), MANN+HUMMEL International GmbH & Co. KG (Germany), Meissner Filtration Products, Inc. (US), Cole-Parmer Instrument Company, LLC (US), Applexion (France), Cantel Medical Corp. (US), W. L. Gore & Associates Inc. (US), Membrane Solutions (US), Amazon Filters Ltd. (UK), Toyo Roshi Kaisha, Ltd. (Japan), Porvair plc (UK), Sterlitech Corporation (US), Synder Filtration, Inc. (US), Graver Technologies, LLC (US), Koch Membrane Systems, Inc. (US), Nupore Filtration Systems (India), and Cobetter Filtration Equipment Co., Ltd. (China).
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%
Recent Developments of Pharmaceutical Membrane Filtration Industry:
- Repligen Corporation (US) launched a holder-free, self-contained tangential flow filtration (TFF) device for the advancement of downstream flat sheet TFF technology for ultrafiltration and diafiltration (UF/DF).
- Cytiva (US) announced the opening of a 33,000 ft2 manufacturing facility in Pune, India. The new facility will manufacture bioprocessing equipment such as tangential flow, virus filtration, and inactivation systems.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=255408031
Related Reports:
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html